Association between intrinsic capacity, changes in intrinsic capacity, and cardiometabolic multimorbidity: results

Ziyue Wang1,2, Lu Wang1, Lulu Tang1

  • 1Department of Nursing, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

PubMed

Insights

Intrinsic capacity (IC) decline is linked to higher cardiometabolic multimorbidity (CMM) risk. Even with improved IC, risk persists, highlighting the need for targeted interventions to manage CMM in aging populations.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Intrinsic capacity (IC) is crucial for maintaining cardiometabolic health in older adults.
  • Declining IC is associated with increased risk of developing multiple chronic conditions.
  • Understanding the relationship between IC and cardiometabolic multimorbidity (CMM) is vital for preventative health strategies.

Purpose of the Study:

  • To investigate the association between baseline IC, cumulative IC scores, and dynamic changes in IC with the risk of incident CMM.
  • To analyze how different levels of IC and its changes over time impact CMM development.

Main Methods:

  • Utilized data from three large prospective cohort studies: CHARLS, ELSA, and HRS.
  • Employed Kaplan-Meier curves and Cox proportional hazards models to assess risk trends and associations.
  • Included 11,916 eligible participants for the analysis.

Main Results:

  • Higher baseline IC reduction was associated with significantly increased CMM risk (HR=1.40).
  • Cumulative IC scores demonstrated a dose-response relationship with CMM risk, with substantial reductions (>1 SD) showing the highest risk (HR=1.61).
  • Dynamic changes in IC also predicted CMM risk; persistent impairment (HR=1.63) and even improvement (HR=1.28) carried higher risks than stable, intact IC.

Conclusions:

  • Both the level of intrinsic capacity and its changes over time are significant predictors of cardiometabolic multimorbidity risk.
  • Even individuals experiencing improvements in IC remain at a higher risk compared to those with consistently intact IC.
  • Developing precise strategies to mitigate IC decline and implementing individualized interventions are essential for effective CMM prevention and management.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
422